Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
August 23, 2016 - Marriott Hotel, Zurich, Switzerland
June 7-10, 2016 - Grand Hyatt, New York - USA
April 12, 2016 - Congress Center Basel, Hall 4, Basel - Switzerland